FGFR2 fusions, seen in around 13–14% of patients in intracellular cholangiocarcinoma (iCCA), have been identified as an oncogenic events driven in iCCA [43–46]. This evidence concerns the gene FGFR2 and infantile convulsions and choreoathetosis.